Cargando…
The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
PURPOSE: Subretinal injection (SRI) in mice is widely used in retinal research, yet the learning curve (LC) of this surgically challenging technique is unknown. METHODS: To evaluate the LC for SRI in a murine model, we analyzed training data from three clinically trained ophthalmic surgeons from 201...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934552/ https://www.ncbi.nlm.nih.gov/pubmed/35275207 http://dx.doi.org/10.1167/tvst.11.3.13 |
_version_ | 1784671872376373248 |
---|---|
author | Huang, Peirong Narendran, Siddharth Pereira, Felipe Fukuda, Shinichi Nagasaka, Yosuke Apicella, Ivana Yerramothu, Praveen Marion, Kenneth M. Cai, Xiaoyu Sadda, Srinivas R. Gelfand, Bradley D. Ambati, Jayakrishna |
author_facet | Huang, Peirong Narendran, Siddharth Pereira, Felipe Fukuda, Shinichi Nagasaka, Yosuke Apicella, Ivana Yerramothu, Praveen Marion, Kenneth M. Cai, Xiaoyu Sadda, Srinivas R. Gelfand, Bradley D. Ambati, Jayakrishna |
author_sort | Huang, Peirong |
collection | PubMed |
description | PURPOSE: Subretinal injection (SRI) in mice is widely used in retinal research, yet the learning curve (LC) of this surgically challenging technique is unknown. METHODS: To evaluate the LC for SRI in a murine model, we analyzed training data from three clinically trained ophthalmic surgeons from 2018 to 2020. Successful SRI was defined as either the absence of retinal pigment epithelium (RPE) degeneration after phosphate buffered saline injection or the presence of RPE degeneration after Alu RNA injection. Multivariable survival-time regression models were used to evaluate the association between surgeon experience and success rate, with adjustment for injection agents, and to calculate an approximate case number to achieve a 95% success rate. Cumulative sum (CUSUM) analyses were performed and plotted individually to monitor each surgeon's simultaneous performance. RESULTS: Despite prior microsurgery experience, the combined average success rate of the first 50 cases in mice was only 27%. The predicted SRI success rate did not reach a plateau above 95% until approximately 364 prior cases. Using the 364 training cases as a cutoff point, the predicted probability of success for cases 1 to 364 was 65.38%, and for cases 365 to 455 it was 99.32% (P < 0.0001). CUSUM analysis showed an initial upward slope and then remained within the decision intervals with an acceptable success rate set at 95% in the late stage. CONCLUSIONS: This study demonstrates the complexity and substantial LC for successful SRI in mice with high confidence. A systematic training system could improve the reliability and reproducibility of SRI-related experiments and improve the interpretation of experimental results using this technique. TRANSLATIONAL RELEVANCE: Our prediction model and monitor system allow objective quantification of technical proficiency in the field of subretinal drug delivery and gene therapy for the first time, to the best of our knowledge. |
format | Online Article Text |
id | pubmed-8934552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-89345522022-03-21 The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons Huang, Peirong Narendran, Siddharth Pereira, Felipe Fukuda, Shinichi Nagasaka, Yosuke Apicella, Ivana Yerramothu, Praveen Marion, Kenneth M. Cai, Xiaoyu Sadda, Srinivas R. Gelfand, Bradley D. Ambati, Jayakrishna Transl Vis Sci Technol Article PURPOSE: Subretinal injection (SRI) in mice is widely used in retinal research, yet the learning curve (LC) of this surgically challenging technique is unknown. METHODS: To evaluate the LC for SRI in a murine model, we analyzed training data from three clinically trained ophthalmic surgeons from 2018 to 2020. Successful SRI was defined as either the absence of retinal pigment epithelium (RPE) degeneration after phosphate buffered saline injection or the presence of RPE degeneration after Alu RNA injection. Multivariable survival-time regression models were used to evaluate the association between surgeon experience and success rate, with adjustment for injection agents, and to calculate an approximate case number to achieve a 95% success rate. Cumulative sum (CUSUM) analyses were performed and plotted individually to monitor each surgeon's simultaneous performance. RESULTS: Despite prior microsurgery experience, the combined average success rate of the first 50 cases in mice was only 27%. The predicted SRI success rate did not reach a plateau above 95% until approximately 364 prior cases. Using the 364 training cases as a cutoff point, the predicted probability of success for cases 1 to 364 was 65.38%, and for cases 365 to 455 it was 99.32% (P < 0.0001). CUSUM analysis showed an initial upward slope and then remained within the decision intervals with an acceptable success rate set at 95% in the late stage. CONCLUSIONS: This study demonstrates the complexity and substantial LC for successful SRI in mice with high confidence. A systematic training system could improve the reliability and reproducibility of SRI-related experiments and improve the interpretation of experimental results using this technique. TRANSLATIONAL RELEVANCE: Our prediction model and monitor system allow objective quantification of technical proficiency in the field of subretinal drug delivery and gene therapy for the first time, to the best of our knowledge. The Association for Research in Vision and Ophthalmology 2022-03-11 /pmc/articles/PMC8934552/ /pubmed/35275207 http://dx.doi.org/10.1167/tvst.11.3.13 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Article Huang, Peirong Narendran, Siddharth Pereira, Felipe Fukuda, Shinichi Nagasaka, Yosuke Apicella, Ivana Yerramothu, Praveen Marion, Kenneth M. Cai, Xiaoyu Sadda, Srinivas R. Gelfand, Bradley D. Ambati, Jayakrishna The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons |
title | The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons |
title_full | The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons |
title_fullStr | The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons |
title_full_unstemmed | The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons |
title_short | The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons |
title_sort | learning curve of murine subretinal injection among clinically trained ophthalmic surgeons |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934552/ https://www.ncbi.nlm.nih.gov/pubmed/35275207 http://dx.doi.org/10.1167/tvst.11.3.13 |
work_keys_str_mv | AT huangpeirong thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT narendransiddharth thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT pereirafelipe thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT fukudashinichi thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT nagasakayosuke thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT apicellaivana thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT yerramothupraveen thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT marionkennethm thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT caixiaoyu thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT saddasrinivasr thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT gelfandbradleyd thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT ambatijayakrishna thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT huangpeirong learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT narendransiddharth learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT pereirafelipe learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT fukudashinichi learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT nagasakayosuke learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT apicellaivana learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT yerramothupraveen learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT marionkennethm learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT caixiaoyu learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT saddasrinivasr learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT gelfandbradleyd learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons AT ambatijayakrishna learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons |